PE / VC
1996
$3 000 M
Boston, Massachusetts, United States
Investment Ticket
Investment Horizon
Investment Stage
Exit Strategy
Profile
MPM Capital is a world-leading biotechnology investment firm with nearly three decades of experience creating and investing in companies that seek to translate scientific innovations into cures for major diseases. With its world-class team and deep experience in scientific research, clinical development, and company-building, MPM strives to power novel medical breakthroughs that transform patients’ lives. MPM invests across the biotech landscape with early-stage venture capital funds, and with impact and public equities products through its affiliate BioImpact Capital.
Industry
Region of investment
MPM Capital Funds
| Name | Type |
|
|
|
Size | AUM | Launch date |
|---|---|---|---|---|---|---|---|
|
MPM Bio 2014 NVS Strategic Fund
|
Venture Capital (VC)
|
Biotechnology
Healthcare Services
Medical Devices
HealthTech
|
Pre-seed
Seed
Series A
|
North America
Europe
|
$5-10 m
|
$54 M
|
June 2014
|
|
MPM BioVentures 2014 LP
|
Venture Capital (VC)
|
Biotechnology
Financial Services
Fintech
Healthcare Services
Medical Devices
|
Pre-seed
Seed
Series A
|
North America
Europe
|
$5-10 m
|
$351 M
|
May 2015
|
|
MPM Oncology Impact Fund I
|
Venture Capital (VC)
|
Biotechnology
Financial Services
Fintech
Medical Devices
|
Pre-seed
Seed
Series A
|
North America
|
$5-10 m
|
$471 M
|
May 2016
|
|
MPM Oncology Innovations Fund
|
Venture Capital (VC)
|
Biotechnology
Financial Services
Fintech
Healthcare Services
Medical Devices
|
Pre-seed
Seed
Series A
|
North America
Europe
|
$5-10 m
|
$100 M
|
February 2019
|